Osteoporosis Clinical Trials

Showing 521-540 of 595 trials

Low Energy Availability, Menstrual Irregularity, and Low Bone Mass

NCT01059968

This study examines the role of energy availability on menstrual function and bone mass in female adolescent endurance athletes. Specific evaluations include dietary intake, exercise energy expenditure, training schedules, menstrual function and bone density.

Bone DensityEnergy Availability

USDA, Western Human Nutrition Research Center45 participantsStarted Sep 2008

Davis, California, United States

COMPLETED

Back Pain in Patients With Severe Osteoporosis

NCT00761332

The purpose of this study is to compare the effectiveness of teriparatide versus therapies that decrease bone loss to prevent new or worsening back pain in patients with osteoporosis seen in clinical practice.

Osteoporosis

Eli Lilly and Company650 participantsStarted Feb 2008

Pokfulam, Hong Kong • Ahmedabad, India • Gurgaon, India +12 more locations

Low Energy Availability, Menstrual Irregularity, and Low Bone Mass

Back Pain in Patients With Severe Osteoporosis

Related Searches

Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Longitudinal Assessment of Bone Growth in Children With Cerebral Palsy

Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women

A School-Based Osteoporosis Prevention Program for Adolescent Girls

Phase 3 Clinical Trial of Teriparatide in Japan

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Motor Control Exercise in Osteoporotic Women

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Bone Density of Large Newborn Infants and Infants of Diabetic Mothers

Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis